InSyBio showcasing its breakthrough technology in investment Community of Texas

ISyBio is showcasing as one of 7 prestigious companies during The International Accelerator’s Demo Day taking place October 22nd, 2019 at 4:30pm.

As one of the leading companies in targeted biomarker discovery, InSyBio is revolutionizing both the medical and food/nutrition research fields. We drive innovation in both clinical trials and drug discovery through our proprietary analysis approach and have been validated through numerous pilot projects and high-level publications in areas such as Cancer, Nutrition and Neurodegenerative diseases. Bellow follows an indicative list of our latest press releases:

To continue this success, InSyBio is seeking a round A of investment money ($2.0m) to:

  • Accelerate the commercialization of InSyBio research tools
  • Commercialize own identified biomarkers through diagnostic and prognostic tests for key diseases (e.g. Stroke, Brain Tumors, Nutrition etc.)
  • Continue R&D
  • Establish the lab infrastructure for biomarkers.
  • Further penetrate US market and reach the 500,000 target labs (pharma, research, nutrition etc.)

Demo Day Agenda:

4:30pm – 5:30pm: Networking and Refreshments

5:30pm – 7:30pm: Live Pitching

7:30pm – 8:00pm: Networking and Closing Remarks

Address: 8121 Bee Caves Rd. Austin, TX. 78747

If you are interested in attending to this event please RSVP to our Director of Business Development, Mackenzie Hastings, no later than October 18th at

About InSyBio: InSyBio is an international pioneer bioinformatics revolutionizing the medical field, clinical trials and food/nutrition industries through targeted biomarker discovery and highly-accurate predictive analytics.

Its solutions provide the R&D departments of Pharma, Research Institutes and Food/Nutrition companies, with the means both analytically and computationally to meet their challenging research and innovation goals (such as robust biomarker discovery and accurate predictive models). This is done through a sophisticated, software-as-a-service, machine learning platform which comprehensively integrates multi-omics data reducing the number of samples and additional validation experiments needed. Since 2013, InSyBio has worked with hundreds of academics, large and small companies, hospitals and research centers allowing them to succeed in their biomarker discovery tasks with an increase of at least 10% in predictive accuracy and decrease of at least 80% in overall time and cost.

Visit to see how InSyBio can help you reach your R&D goals in the era of Precision Medicine and Nutrition.

About International Accelerator: The International Accelerator is the only U.S. accelerator focused solely on investing in companies with non-U.S. citizen founders. IA provides access to seed funding, quality mentors, and services foreign-born entrepreneurs need to scale up their businesses in the United States. The International Accelerator is more than an accelerator program. It is a trusted co-founder for stateside ventures and dedicated to helping non-U.S. citizen entrepreneurs set up their U.S. company, give it an “American look and feel,” and lay a sturdy foundation to build a global business. The experienced team leverages years of international business, design, and entrepreneurial expertise, as well as access to industry experts, active investors and potential customers. At IA, the goal is to bring startups in and send them out with impressive products and the capability to stand on their own feet. Being entrepreneurs themselves, they clearly know the hardships and worries of the startup process. Apart from money, IA is always available to give the help customized for the founder, so they can focus on their product and developing their vision for the company.

For more News visit our InSyBio Blog.

Scroll to top